Delivery Order SPE2DU25D4211-SPE2DU26FC060

The Defense Logistics Agency awarded a delivery order valued at $14,609.25 to AmerisourceBergen Drug Corp, a pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on January 23, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is expected to be completed by January 23, 2026. The award represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s, substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This IDC serves as a comprehensive global pharmaceutical supply vehicle enabling the delivery of prescription medications, generic drugs, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide.

AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems under the DLA Medical Supply Chain. The company's delivery orders through this IDC demonstrate its capability to efficiently fulfill government contracts across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. The parent organization, Cencora, Inc., competes on a full and open basis for federal contracts and holds additional medical supply agreements with other federal agencies, positioning AmerisourceBergen as a key logistics partner for the Department of Defense healthcare infrastructure.